Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
AIDS Reviews
|
September 22, 2016
Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection
Jesús Troya, José Bascuñana
European Geriatric Medicine
|
October 15, 2021
Geriatric-HIV Medicine: the geriatrician's role
Fátima Brañas, Pablo Ryan, Jesús Troya, et al.
Scandinavian Journal of Infectious Diseases
|
September 14, 2007
Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients
Jesús Troya, Angela Casquero, Elena Refoyo, et al.
Computer Methods and Programs in Biomedicine
|
May 29, 2024
Artificial intelligence model for tumoral clinical decision support systems
Guillermo Iglesias, Edgar Talavera, Jesús Troya, et al.
Open Forum Infectious Diseases
|
September 27, 2017
Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients
Jesús Troya, Guillermo Cuevas, Pablo Ryan, et al.
AIDS (London, England)
|
March 22, 2018
High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis
Jorge Valencia, Pablo Ryan, Alejandro Alvaro-Meca, et al.
Journal of Clinical Medicine
|
February 11, 2023
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV)
Jesús Troya, Roberto Pedrero-Tomé, Luis Buzón, et al.
Plos One
|
October 4, 2018
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
Jorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2021
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care
Jorge Valencia, Jeffrey V Lazarus, Francisco C Ceballos, et al.
International Journal of STD & AIDS
|
July 7, 2020
Health care issues affecting transgender people living with HIV: an opportunity for improvement
Jesús Troya, Jorge Del Romero, Pablo Ryan, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
AIDS Reviews
|
September 22, 2016
Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection
Jesús Troya, José Bascuñana
European Geriatric Medicine
|
October 15, 2021
Geriatric-HIV Medicine: the geriatrician's role
Fátima Brañas, Pablo Ryan, Jesús Troya, et al.
Scandinavian Journal of Infectious Diseases
|
September 14, 2007
Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients
Jesús Troya, Angela Casquero, Elena Refoyo, et al.
Computer Methods and Programs in Biomedicine
|
May 29, 2024
Artificial intelligence model for tumoral clinical decision support systems
Guillermo Iglesias, Edgar Talavera, Jesús Troya, et al.
Open Forum Infectious Diseases
|
September 27, 2017
Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients
Jesús Troya, Guillermo Cuevas, Pablo Ryan, et al.
AIDS (London, England)
|
March 22, 2018
High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis
Jorge Valencia, Pablo Ryan, Alejandro Alvaro-Meca, et al.
Journal of Clinical Medicine
|
February 11, 2023
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV)
Jesús Troya, Roberto Pedrero-Tomé, Luis Buzón, et al.
Plos One
|
October 4, 2018
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
Jorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2021
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care
Jorge Valencia, Jeffrey V Lazarus, Francisco C Ceballos, et al.
International Journal of STD & AIDS
|
July 7, 2020
Health care issues affecting transgender people living with HIV: an opportunity for improvement
Jesús Troya, Jorge Del Romero, Pablo Ryan, et al.
Page
of 6